Showing results (61-70 of 374) with videos related to
Sort By:
Pageof 38
Neurourology and Urodynamics|April 16, 2009
Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinenceHann-Chorng Kuo, Hsin-Tzu Liu, Michael B ChancellorAmerican Journal of Physical Medicine & Rehabilitation|May 23, 2006
Pharmacotherapy for neurogenic detrusor overactivityMichael B Chancellor, Rodney U Anderson, Timothy B BooneReviews in Urology|September 3, 2010
Can urinary nerve growth factor be a biomarker for overactive bladder?Hann-Chorng Kuo, Hsin-Tzu Liu, Michael B ChancellorInternational Journal of Urology : Official Journal of the Japanese Urological Association|January 23, 2013
Intravesical drug delivery for dysfunctional bladderChun-Chien Hsu, Yao-Chi Chuang, Michael B ChancellorReviews in Urology|September 21, 2006
Advances toward tissue engineering for the treatment of stress urinary incontinenceRon Jankowski, Ryan Pruchnic, Michael Hiles, et al.Urology|February 8, 2006
15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in ratsHitoshi Masuda, Michael B Chancellor, Kazunori Kihara, et al.BJU International|May 21, 2008
Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in womenHsin-Tzu Liu, Michael B Chancellor, Hann-Chorng KuoEuropean Urology|May 13, 2008
Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injectionHsin-Tzu Liu, Michael B Chancellor, Hann-Chorng KuoThe Urologic Clinics of North America|October 3, 2006
The overactive bladder: Epidemiology and morbidityShachi Tyagi, Catherine A Thomas, Yukio Hayashi, et al.Urology Practice|May 5, 2023
A Cost, Time, and Demographic Analysis of Participant Recruitment and Urine Sample Collection Through Social Media OptimizationPrasun Sharma, Laura E Lamb, Sarah N Bartolone, et al.Pageof 38